Vomiting
217
14
14
131
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
36 trials with published results (17%)
Research Maturity
131 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.2%
20 terminated out of 217 trials
86.8%
+0.2% vs benchmark
31%
67 trials in Phase 3/4
27%
36 of 131 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 131 completed trials
Clinical Trials (217)
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin
Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
GI Alpha-Gal Study
Mandala Painting During Chemotherapy
Balanced Crystalloid vs Normal Saline in Pediatric Acute Gastroenteritis
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Subcutaneous Route and Pharmacology of Metoclopramide
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Management of Nausea and Vomiting Chemotherapy-induced in Normandy
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
Inhaled Isopropyl Alcohol for Treatment of Nausea
The 4-7-8 Breathing Technique on Pain and Nausea-Vomiting
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
The Effect of Children's Laughter Video on Oncology Patient
Accupressure of P6 to Reduce Nausea During Cesarean Section
Sucrose at Triage for Acute Gastroenteritis Episode in Children
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments